Springboard Enterprises

Panakeia simplifies and accelerates cancer diagnosis through its AI-driven diagnostics platform. By analyzing biopsy images, it helps pathologists locate cancer tissues, enabling precise visual analysis of tissue samples, ultimately reducing diagnostic costs per patient.

Concerto Biosciences develops microbe-based products that rebuild microbial communities in and around humans and ecosystems. The company uses an ultra-high-throughput platform to experimentally measure millions of microbial interactions and map interaction networks, enabling the discovery of ensembles, which are specific combinations of microbes that work together to shepherd damaged microbial communities back to health. These ensembles have potential applications across medicine and agriculture, addressing global challenges in health, food, and industry. By focusing on microbial community engineering, Concerto aims to become a leading inventor of ensembles and to redefine how microbiomes are leveraged for health and environmental outcomes.

RT MicroDx is a healthcare technology company that specializes in developing accurate, affordable, and user-friendly at-home molecular testing solutions. Their innovative platform, designed for detecting bacterial or viral pathogens in saliva, combines the sensitivity and selectivity of DNA amplification molecular tests with the affordability of rapid antigen tests, empowering patients with an accessible diagnostic tool.

Urban Innovations is a real estate investment and development company based in Chicago, Illinois. It focuses on the management, leasing, and construction of creative loft office spaces. With expertise in property management, Urban Innovations aims to enhance urban environments by transforming properties into innovative workspaces that cater to the needs of modern businesses. The company is committed to revitalizing urban areas through strategic real estate projects and effective property management practices.

Aloe Therapeutics focuses on developing innovative cancer therapies. Its flagship treatment is designed to enhance the effectiveness of commonly used therapies while minimizing systemic toxicity, targeting solid tumors. This approach aims to provide patients with challenging cancers access to cell therapy options without the need for personalized treatments.

Phiogen is a biotechnology company specializing in the development of next-generation therapeutics using bacteriophages. With over a decade of research in phage biology, Phiogen's platform enables personalized phage therapy for treating critical infections and resistant bacteria.

Revealix Inc., established in 2014 and based in Austin, Texas, specializes in digital health solutions aimed at improving the care of diabetic patients. The company has developed an analytics medical software platform that enables the early detection of skin diseases and diabetic limb complications. By utilizing mobile imaging and connected health tools, Revealix provides healthcare providers with an affordable web-based system for monitoring and analyzing potential complications. This innovative approach allows for preemptive monitoring, facilitating timely interventions and enhancing patient outcomes in the management of diabetic limb health.

RubyWell is an intelligent and automated guide that helps family caregivers regain financial stability by continuously discovering and delivering new savings, benefits, and compensation opportunities.

Cellens is a medical device company based in Medford, Massachusetts, and is a spinoff from Tufts University, established in 2019. The company focuses on enhancing cancer detection through noninvasive screening methods. It has developed a cell surface scanning platform that utilizes atomic force microscopy imaging and machine learning to assist oncologists in the detection of bladder cancer. By analyzing physio-biomarkers on cell surfaces derived from urine samples, Cellens provides a diagnostic score that helps healthcare professionals minimize the need for invasive and costly procedures, thereby improving patient outcomes in bladder cancer diagnostics.

CurieDx develops AI-driven diagnostic tools that analyze medical images to enhance cancer diagnoses. Utilizing smartphone images and deep learning algorithms, the company facilitates remote healthcare by integrating its tools with telehealth platforms.

Social Cascade is a SaaS organization dedicated to fostering healthy communities by promoting awareness and empathy. It operates a social platform designed to help children prepare mentally and socially for academic success.

FamilyWell Health is a digital health company that integrates behavioral health services into obstetric practices. It offers a tech-enabled, collaborative care approach to address the maternal mental health crisis in the U.S., focusing on equitable and affordable access to mental health services for pregnant and postpartum patients. The company provides in-person and virtual care, including psychiatric consultations, licensed therapy, health coaching, and peer-to-peer text message support throughout the perinatal journey. It also guides providers on medication management, ensuring easy access to mental health care for patients.

Ad Astra Diagnostics specializes in manufacturing point-of-care blood testing devices. These devices, utilizing dry reagent technology, deliver rapid and accurate blood analysis, including complete blood counts, at the patient's bedside. This enables healthcare providers to make timely clinical decisions without the need for traditional laboratory testing.

Surgo Health employs artificial intelligence to analyze individual behavioral patterns, enabling healthcare providers to tailor strategies effectively.

Cubtale is an AI-powered care guidance platform for parents and caregivers that centralizes baby care information and supports real-time decisions. The platform provides real-time content, product recommendations, and expert guidance drawn from proprietary care data and medical guidelines. It enables parents to track and analyze a baby's growth, feeding routines, and health milestones and to schedule consultations with baby care experts.

Liv Labs specializes in developing convenient and affordable solutions for improving pelvic floor fitness.

juli is a digital healthcare startup founded in 2020, aimed at improving the lives of individuals with chronic conditions. The company develops an artificial intelligence-powered application that consolidates diverse healthcare data into a single platform. This application supports users dealing with various chronic health issues, such as asthma, migraines, depression, bipolar disorder, and chronic pain. By integrating data from smartphones, wearables, and self-reported information, juli enables users to self-track and manage their symptoms effectively. The founders, motivated by personal experiences with chronic conditions, leverage their expertise in big data to enhance healthcare outcomes and promote better understanding of health triggers and management strategies.

Rootines provides data collection and analysis for pediatric complex chronic conditions. Focused on early intervention and connecting the care team, Rootines marries patient reported outcomes with remote patient monitoring. An easy to use, consumer focused app allows for easy data entry and our device agnostic approach to integrations allows for as much data collection as possible. Our main customers are hospitals/therapist offices, clinicians and payers.

NeuroGeneces develops an artificial intelligence driven brain health assessment platform to detect early signs of neurodegeneration before cognitive symptoms appear. Its Brain Age test analyzes patient EEG data collected via a sleep headband and ML software, benchmarking against a proprietary normative database to provide objective measures of brain function. The platform enables healthcare practitioners to identify at-risk individuals and guide preventive interventions through early behavioral strategies, offering more comprehensive insights than traditional biomarkers.

Finclude is a company that has developed a pan-European credit scoring system aimed at enabling businesses to evaluate consumers' creditworthiness based on their transactional behavior, irrespective of their credit history. The platform aggregates and interprets transactional data from various banks, allowing for a comprehensive assessment of an individual's affordability and creditworthiness. This innovative approach assists customers in making informed credit decisions by providing a clearer view of potential borrowers' financial behaviors and capabilities. Finclude's solution addresses the limitations of traditional credit scoring methods, thereby expanding access to credit for a broader range of individuals.

EpiSoft is a privately owned eHealth company located in Sydney, specializing in the design and development of cloud-based software tailored for the clinical and practice management of complex chronic diseases. The company's offerings include advanced medical systems that facilitate care coordination, management, and treatment planning. EpiSoft's software solutions encompass tools for cancer care, mental health, and liver care, as well as custom clinical applications for non-acute admissions. By providing digital medical prescriptions and treatment options, EpiSoft supports medical businesses, hospitals, and clinics in enhancing patient care and streamlining their operational processes.

Markable Creators leverages AI-powered computer vision to enable social visual discovery shopping. It bridges the gap between social content and e-commerce by allowing viewers to shop clothing seen in videos across various platforms. The company offers a fully-automated solution, connecting with major global e-commerce platforms and live on prominent Asian social content platforms.

The OYA team is a multifaceted group of product designers, researchers, athletes, stylists, doctors, manufacturers, marketers, and venture capitalists. We are united by our common goal to combat feminine health issues with sportswear.

Dionysus Digital Health develops an epigenetic testing platform that predicts and diagnoses conditions such as postpartum depression by analyzing stress patterns and hormonal changes. This enables early identification of at-risk individuals, allowing healthcare providers to facilitate timely interventions like therapy or medication.

Nalu Bio is a biotechnology company specializing in the chemical synthesis of cannabinoids (CBD), aiming to provide pure, safe ingredients that are environmentally sustainable. Unlike traditional plant-based methods, Nalu Bio's approach uses significantly less land, water, and energy, while maintaining high purity standards (0% THC) without relying on chemicals or pesticides.

LUWI develops a hormone-free, latex-free contraceptive protection cover designed to protect sexual health and give women control over their protection. The product is positioned as an alternative to condoms, focusing on discreet protection that preserves sensation while offering single-use reliability. The company emphasizes female agency and a protection option that avoids hormones and latex. LUWI was founded in 2015 and is headquartered in Chicago, Illinois.

Vaginal Biome Science is a biotechnology company dedicated to maintaining and restoring the vaginal microbiome, a complex ecosystem of microorganisms vital for women's health. The company develops innovative diagnostics and therapies that target this microbiome, aiming to protect and restore its balance, thereby enhancing women's overall health and well-being, improving disease prevention and treatment outcomes, and potentially boosting sexual satisfaction.

Couplet Care manufactures a medical infant bassinet designed to reduce patient risks, improve clinical productivity, and strengthen bonding between parents and their newborns in the postnatal unit. The product connects parents and babies and supports treating mothers and infants together in the same space, aiming to enhance patient safety, streamline clinical workflows, and promote positive health outcomes for both mother and child.

Calla Lily Clinical Care is a women's health company focused on developing innovative drug delivery systems. Their proprietary platform, Callavid®, enables intravaginal drug delivery for various indications, including fertility and pregnancy support, prevention of recurrent bacterial vaginosis, hormone replacement therapy for menopause, and biomarker-based diagnostic tests.

SimpliFed is a telehealth company that offers virtual breastfeeding support and broader maternal care services to new and pregnant parents. Founded in 2020, it addresses challenges such as sleep deprivation, uncertainty, and complex infant nutrition questions. The company builds trusted relationships with parents and partners with healthcare payers and providers to deliver a comprehensive maternal health operating system covering pregnancy, postpartum, and baby feeding.

Emagine Solutions Technology, LLC is a Tucson, Arizona-based company specializing in mobile ultrasound imaging technology. Its flagship product, VistaScan, converts standard mobile devices into advanced ultrasound imaging tools, enhancing diagnostic capabilities in medical settings. The company is developing its innovative technology at the Arizona Center for Innovation, a business incubator located within the UA Tech Park, where it benefits from various business assistance programs and facilities designed to support emerging technology firms. Emagine Solutions Technology aims to improve healthcare delivery through its cutting-edge solutions.

CurioInvest is a financial technology company specializing in the tokenization of real-world assets, with a primary focus on collectible and rare exclusive cars. By leveraging blockchain technology, CurioInvest aims to make investments in this lucrative market accessible to a broader audience, eliminating high capital requirements and costly intermediaries. The company recognizes that collectible cars have significantly outperformed traditional investment indices since 2008 and seeks to pioneer the adoption of distributed ledger technologies within the automotive sector. Through its innovative platform, CurioInvest enables investors to directly participate in the market for high-value collectibles, simplifying the investment process and fostering a new era of asset ownership.

Feminai is a healthcare clinic specializing in advanced breast cancer screening solutions. The company has developed a wearable medical device that focuses on providing an efficient and safe method for early cancer detection. By leveraging technology and artificial intelligence, Feminai's platform offers personalized medicine and enhances the screening process, empowering women to improve their chances of identifying breast cancer at an early stage. Through its innovative approach, Feminai aims to revolutionize breast cancer detection and contribute to better health outcomes for women.

Vella Bioscience is a health-tech company focused on enhancing female sexual empowerment through innovative products. Its flagship offering, Vella, is a unique nano-encapsulated topical lotion designed specifically for women seeking to improve their sexual experiences. This product is formulated to promote easier, more intense, and more frequent orgasms, irrespective of hormonal status. Vella is notable for being the first lotion that relaxes vaginal smooth muscle, which is essential for sexual response. Additionally, it is the only cannabidiol-based sexual enhancement formulation that has undergone clinical validation in studies involving women aged 23 to 61. Vella Bioscience aims to address the unmet needs related to women's sexual pleasure and well-being through clinically validated and patented solutions.